TNFRSF11A and neoplasm: The RANK/RANKL signalling, as discussed before, induces an osteolytic and immunosuppressive PMN in bone via the induction of osteoclastogenesis [66] and Treg expansion [46], which suggests targeting RANK/RANKL will potentially be effective in preventing PMN formation and bone metastasis by tumours.